Literature DB >> 29134776

Acute chest syndrome among children hospitalized with vaso-occlusive crisis: A nationwide study in the United States.

Takuto Takahashi1, Yusuke Okubo2,3, Atsuhiko Handa4.   

Abstract

PURPOSE: Acute chest syndrome (ACS) is a common complication among pediatric inpatients with sickle cell disease and vaso-occlusive crisis (VOC). However, little is known about the factors associated with ACS complication. The present study assessed the epidemiological features of children hospitalized with VOC and ascertained factors associated with ACS complication.
METHODS: Hospital discharge records of patients with VOC aged <20 years were obtained for the years 2003, 2006, 2009, and 2012 from the Kids' Inpatient Database. Data were weighted to estimate the annual hospitalization rates with respect to gender and race/ethnicity in the United States. Multivariable logistic regression was conducted to ascertain factors associated with ACS complication after adjusting for patient and hospital characteristics.
RESULTS: The total annual hospitalizations for VOC increased from 22,511 in 2003 to 24,292 in 2012. Multivariable logistic regression analysis showed that children aged 5-9 years had 2.59 times higher odds of ACS than children aged 15-19 years (95% confidence interval [CI], 2.32-2.88). Comorbidity of asthma (odds ratio [OR], 1.42; 95% CI, 1.31-1.54) and obstructive sleep apnea (OR, 1.70; 95% CI, 1.31-2.20) were associated with ACS development. ACS was also associated with male gender and the summer and fall seasons.
CONCLUSION: We reported nationwide estimates of the annual hospitalization rate for childhood VOC in the United States and demonstrated the major risk factors associated with ACS complication. Vigilance is needed for ACS complications in high-risk VOC admissions.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute chest syndrome; epidemiology; hospitalization; kids’ inpatient database; sickle cell disease; vaso-occlusive crisis

Mesh:

Year:  2017        PMID: 29134776     DOI: 10.1002/pbc.26885

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Predictors of Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: A Retrospective Case-Control Study.

Authors:  Abdullah A Yousef; Hwazen A Shash; Ali N Almajid; Ammar A Binammar; Hamza Ali Almusabeh; Hassan M Alshaqaq; Mohammad H Al-Qahtani; Waleed H Albuali
Journal:  Children (Basel)       Date:  2022-06-15

2.  The burden of obstructive sleep apnea in pediatric sickle cell disease: a Kids' inpatient database study.

Authors:  Po-Yang Tsou; Christopher M Cielo; Melissa S Xanthopoulos; Yu-Hsun Wang; Pei-Lun Kuo; Ignacio E Tapia
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

3.  Seasonal manifestations of sickle cell disease activity.

Authors:  Chunliang Xu; Paul S Frenette
Journal:  Nat Med       Date:  2019-04       Impact factor: 87.241

4.  Antibiotic Use and Respiratory Pathogens in Adults With Sickle Cell Disease and Acute Chest Syndrome.

Authors:  Alyssa M Claudio; Lindsey Foltanski; Tracie Delay; Ashley Britell; Ashley Duckett; Erin R Weeda; Nicole Bohm
Journal:  Ann Pharmacother       Date:  2019-04-23       Impact factor: 3.154

5.  Identification of Clinical and Laboratory Parameters Associated with the Development of Acute Chest Syndrome during Vaso-Occlusive Episodes in Children with Sickle Cell Disease: A Preliminary Step before Assessing Specific and Early Treatment Strategies.

Authors:  Fouad Madhi; Annie Kamdem; Camille Jung; Adele Carlier-Gonod; Sandra Biscardi; Jeremy Busca; Cecile Arnaud; Isabelle Hau; David Narbey; Ralph Epaud; Corinne Pondarre
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

Review 6.  Advances in the diagnosis and treatment of sickle cell disease.

Authors:  A M Brandow; R I Liem
Journal:  J Hematol Oncol       Date:  2022-03-03       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.